New College of American Pathologists Guideline Improves Testing, Care, for Patients With Diffuse Gliomas
February 18, 2022
February 18, 2022
NORTHFIELD, Illinois, Feb. 18 (TNSJou) -- The College of American Pathologists issued the following news release on Feb. 17, 2022:
A new evidence-based guideline published today by the College of American Pathologists (CAP) can help improve how pediatric and adult patients with the most common type of primary brain tumor, diffuse glioma, are diagnosed and managed.
"Molecular Biomarker Testing for the Diagnosis of Diffuse Gliomas," published in an early online . . .
A new evidence-based guideline published today by the College of American Pathologists (CAP) can help improve how pediatric and adult patients with the most common type of primary brain tumor, diffuse glioma, are diagnosed and managed.
"Molecular Biomarker Testing for the Diagnosis of Diffuse Gliomas," published in an early online . . .